Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Role of Nitric Oxide in Insulin Secretion and Glucose Metabolism.

Bahadoran Z, Mirmiran P, Ghasemi A.

Trends Endocrinol Metab. 2019 Nov 2. pii: S1043-2760(19)30204-8. doi: 10.1016/j.tem.2019.10.001. [Epub ahead of print] Review.

PMID:
31690508
2.

Comparison of Food Intake in Multiple Sclerosis Patients and Healthy Individuals: A Hospital-Based Case-Controlled Study.

Ghazavi Y, Bahadoran Z, Nikfarjam M, Moghaddam NB, Mirmiran P, Heydari MR.

Iran J Child Neurol. 2019 Fall;13(4):143-154.

PMID:
31645874
3.

Elevated serum levels of aminotransferases in relation to unhealthy foods intake: Tehran lipid and glucose study.

Mirmiran P, Gaeini Z, Bahadoran Z, Azizi F.

BMC Endocr Disord. 2019 Oct 15;19(1):100. doi: 10.1186/s12902-019-0437-5.

4.

The Principles of Biomedical Scientific Writing: Discussion.

Ghasemi A, Bahadoran Z, Mirmiran P, Hosseinpanah F, Shiva N, Zadeh-Vakili A.

Int J Endocrinol Metab. 2019 Jul 29;17(3):e95415. doi: 10.5812/ijem.95415. eCollection 2019 Jul. Review.

5.

Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: An updated meta-analysis.

Mirmiran P, Bahadoran Z, Gaeini Z, Moslehi N, Azizi F.

Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):906-915. doi: 10.1016/j.numecd.2019.05.056. Epub 2019 May 14. Review.

PMID:
31377182
6.

The Principles of Biomedical Scientific Writing: Results.

Bahadoran Z, Mirmiran P, Zadeh-Vakili A, Hosseinpanah F, Ghasemi A.

Int J Endocrinol Metab. 2019 Apr 24;17(2):e92113. doi: 10.5812/ijem.92113. eCollection 2019 Apr. Review.

7.

Serum nitric oxide metabolites and hard clinical endpoints: a population-based prospective study.

Bahadoran Z, Mirmiran P, Tahmasebinejad Z, Azizi F, Ghasemi A.

Scand Cardiovasc J. 2019 Aug;53(4):176-182. doi: 10.1080/14017431.2019.1618493. Epub 2019 May 20.

PMID:
31081695
8.

Tea, coffee, caffeine intake and the risk of cardio-metabolic outcomes: findings from a population with low coffee and high tea consumption.

Gaeini Z, Bahadoran Z, Mirmiran P, Azizi F.

Nutr Metab (Lond). 2019 May 3;16:28. doi: 10.1186/s12986-019-0355-6. eCollection 2019.

9.

The Association between Dietary Fat Pattern and the Risk of Type 2 Diabetes.

Gaeini Z, Bahadoran Z, Mirmiran P, Djazayery A.

Prev Nutr Food Sci. 2019 Mar;24(1):1-7. doi: 10.3746/pnf.2019.24.1.1. Epub 2019 Mar 31.

10.

A Brief History of Modern Endocrinology and Definitions of a True Hormone.

Bahadoran Z, Mirmiran P, Azizi F, Ghasemi A.

Endocr Metab Immune Disord Drug Targets. 2019;19(8):1116-1121. doi: 10.2174/1871530319666190326142908.

PMID:
30914038
11.

The Principles of Biomedical Scientific Writing: Materials and Methods.

Ghasemi A, Bahadoran Z, Zadeh-Vakili A, Montazeri SA, Hosseinpanah F.

Int J Endocrinol Metab. 2019 Jan 28;17(1):e88155. doi: 10.5812/ijem.88155. eCollection 2019 Jan. Review.

12.

Estimation and Validation of Dietary Nitrate and Nitrite Intake in Iranian Population.

Bahadoran Z, Ghasemi A, Mirmiran P, Mehrabi Y, Azizi F, Hadaegh F.

Iran J Public Health. 2019 Jan;48(1):162-170.

13.

Circulating markers of nitric oxide homeostasis and cardiometabolic diseases: insights from population-based studies.

Bahadoran Z, Mirmiran P, Jeddi S, Carlström M, Azizi F, Ghasemi A.

Free Radic Res. 2019 Apr;53(4):359-376. doi: 10.1080/10715762.2019.1587168. Epub 2019 Apr 23.

PMID:
30821533
14.

Hyperoxia improves carbohydrate metabolism by browning of white adipocytes in obese type 2 diabetic rats.

Norouzirad R, Ghanbari M, Bahadoran Z, Abdollahifar MA, Rasouli N, Ghasemi A.

Life Sci. 2019 Mar 1;220:58-68. doi: 10.1016/j.lfs.2019.01.045. Epub 2019 Jan 28.

PMID:
30703383
15.

Circulating nitric oxide metabolites and the risk of cardiometabolic outcomes: a prospective population-based study.

Mirmiran P, Bahadoran Z, Tahmasebinejad Z, Azizi F, Ghasemi A.

Biomarkers. 2019 Jun;24(4):325-333. doi: 10.1080/1354750X.2019.1567816. Epub 2019 Feb 15.

PMID:
30624084
16.

Nutrition and Diabetes, Cardiovascular and Chronic Kidney Diseases: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Hosseini-Esfahani F, Moslehi N, Asghari G, Hosseinpour-Niazi S, Bahadoran Z, Yuzbashian E, Mirmiran P, Azizi F.

Int J Endocrinol Metab. 2018 Oct 31;16(4 Suppl):e84791. doi: 10.5812/ijem.84791. eCollection 2018 Oct. Review.

17.

The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Bahadoran Z, Mirmiran P, Jeddi S, Momenan AA, Azizi F, Ghasemi A.

Int J Endocrinol Metab. 2018 Oct 14;16(4 Suppl):e84775. doi: 10.5812/ijem.84775. eCollection 2018 Oct. Review.

18.

Nutrition and Cardio-Metabolic Risk Factors: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Hosseini-Esfahani F, Hosseinpour-Niazi S, Asghari G, Bahadoran Z, Moslehi N, Golzarand M, Ejtahed HS, Mirmiran P, Azizi F.

Int J Endocrinol Metab. 2018 Oct 13;16(4 Suppl):e84772. doi: 10.5812/ijem.84772. eCollection 2018 Oct. Review.

19.

Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Hosseini-Esfahani F, Bahadoran Z, Moslehi N, Asghari G, Yuzbashian E, Hosseinpour-Niazi S, Mirmiran P, Azizi F.

Int J Endocrinol Metab. 2018 Oct 21;16(4 Suppl):e84771. doi: 10.5812/ijem.84771. eCollection 2018 Oct. Review.

20.

Monosodium Glutamate (MSG)-Induced Animal Model of Type 2 Diabetes.

Bahadoran Z, Mirmiran P, Ghasemi A.

Methods Mol Biol. 2019;1916:49-65. doi: 10.1007/978-1-4939-8994-2_3.

PMID:
30535681

Supplemental Content

Loading ...
Support Center